基底细胞癌中氨基酸转运蛋白SLC7A5、SLC7A7、SLC7A8及酶TDO2的表达谱
本研究比较基底细胞癌(BCC)与匹配的非肿瘤臀部皮肤活检组织,用微阵列和/或qPCR检测基因表达,并用免疫组化评估蛋白表达与定位。结果显示BCC中SLC7A5、SLC7A8和TDO2表达上调,SLC7A7未确认上调;作者认为氨基酸转运蛋白可作为未来药物治疗的潜在靶点进一步探索。
要点
- BCC中SLC7A5(P<0.001)、SLC7A8(P<0.001)和TDO2(P=0.002)表达较非肿瘤皮肤升高。
- SLC7A7在qPCR中未确认升高(P=0.50)。
- 免疫组化显示SLC7A5和SLC7A8的肿瘤细胞蛋白表达与基因表达相关。
核心结论
- 本研究强调BCC较非肿瘤皮肤中SLC7A5、SLC7A8和TDO2表达上调。
- 作者认为氨基酸转运蛋白可作为未来药物治疗的潜在靶点进一步探索。
研究设计与样本
- 研究比较BCC活检组织(n=14)与匹配的非肿瘤臀部皮肤活检组织。
- 基因表达用微阵列(n=4+4)和/或qPCR(n=14+14)分析。
- 蛋白表达与定位用免疫组化在福尔马林固定石蜡包埋BCC样本中评估。
主要发现
- 微阵列分析显示BCC中氨基酸转运蛋白SLC7A5、SLC7A7、SLC7A8及胞质酶色氨酸2,3-双加氧酶(TDO)2表达增加。
- qPCR确认SLC7A5(P<0.001)、SLC7A8(P<0.001)和TDO2(P=0.002)表达较高,但SLC7A7(P=0.50)未确认。
- 免疫组化显示SLC7A5和SLC7A8的肿瘤细胞蛋白表达与基因表达相关。
- 免疫组化观察到SLC7A7蛋白表达于颗粒层,TDO2表达于免疫细胞。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of basal cell carcinoma (BCC) is increasing and the costs for care rising. Therefore, the need for simplified and cost-effective treatment choices is substantial. Aberrant signalling in several pathways, induced by ultraviolet radiation, is of importance in the development of BCC. Alterations in tumour metabolic activity are part of general carcinogenesis; however, these alterations are only partially recognized in skin cancer. OBJECTIVES: To study expression profiles in BCCs compared with individually matched nontumour skin, with a focus on finding differences associated with tumour metabolism. MATERIALS AND METHODS: Gene expression in biopsies from BCCs (n = 14) compared with biopsies from nontumour gluteal skin was analysed with microarrays (n = 4 + 4) and/or quantitative real-time polymerase chain reaction (qPCR, n = 14 + 14). Protein expression and localization was assessed using immunohistochemistry (IHC) in formalin-fixed and paraffin-embedded BCC samples. RESULTS: Microarray analysis revealed increased expression of the amino acid transporters SLC7A5, SLC7A7 and SLC7A8 as well as the cytosolic enzyme tryptophan 2,3-dioxygenase (TDO) 2 in BCC. Higher expression of SLC7A5 (P < 0·001), SLC7A8 (P < 0·001) and TDO2 (P = 0·002), but not SLC7A7 (P = 0·50), was confirmed by qPCR, and IHC demonstrated correlating tumour cell protein expression of SLC7A5 and SLC7A8. Protein expression of SLC7A7 was observed in the stratum granulosum, and TDO2 in immune cells. CONCLUSIONS: This study highlights the upregulation of SLC7A5, SLC7A8 and TDO2 in BCC compared with nontumour skin. Our findings imply that amino acid transporters may be further explored as potential targets for future medical treatment.
引用
- Tina E, Prosén S, Lennholm S, et al. Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma. Br J Dermatol. 2018. PMID: 29938775. doi:10.1111/bjd.16905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。